MedTrace Logo

A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD

NCT00457951 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2021-12-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether ODSH, when added to conventional treatment, is more effective in treating COPD exacerbations than conventional therapy alone.

Conditions

Interventions

DRUG

Open-Label

ODSH administered open-label

DRUG

Placebo Comparator: Placebo-Control Arm 0.9% Sodium Chloride

Placebo-Control Arm: Bolus infusion followed by a 96 hour continuous infusion of 0.9%Sodium Chloride

DRUG

ODSH

Randomized, Blinded, ODSH Arm

Sponsors & Collaborators

Principal Investigators

  • Tobias Welte, MD · Hannover Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-08-31
Completion
2009-10-31

Countries

  • United States
  • Belgium
  • Canada
  • Germany
  • Poland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00457951 on ClinicalTrials.gov